Office of the Revisor of Statutes

HF 1183

Status in the House - 92nd Legislature (2021 - 2022)

Current bill text: 2nd Engrossment
Add HF1183 to MyBills
Version List

Companion: SF1265
Companion Text
Senate Search

Revisor number: 21-02806

Long Description

Further Committee Actions

House Research Summary
Fiscal Notes

Engrossments
Introduction PDF	Posted on 02/18/2021
1st Engrossment PDF	Posted on 02/25/2021
2nd Engrossment PDF	Posted on 03/04/2021

Description

Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.

Authors (4)

Actions

House

02/18/2021	Introduction and first reading, referred to Commerce Finance and Policy pg. 472 Intro
02/25/2021	Committee report, to adopt as amended and re-refer to Health Finance and Policy pg. 606a
02/25/2021	Author added Boe pg. 655
03/04/2021	Committee report, to adopt as amended and re-refer to State Government Finance and Elections pg. 771a
03/04/2021	Author added Bierman pg. 823
03/08/2021	Author added Klevorn pg. 891
03/11/2021	Committee report, to adopt and re-refer to Ways and Means pg. 983
03/25/2021	Author added Greenman pg. 1366
04/09/2021	Author stricken Boe pg. 2068

House Actions	Senate Actions
02/18/2021
Introduction and first reading, referred to Commerce Finance and Policy pg. 472 Intro
02/25/2021
Committee report, to adopt as amended and re-refer to Health Finance and Policy pg. 606a Author added Boe pg. 655
03/04/2021
Committee report, to adopt as amended and re-refer to State Government Finance and Elections pg. 771a Author added Bierman pg. 823
03/08/2021
Author added Klevorn pg. 891
03/11/2021
Committee report, to adopt and re-refer to Ways and Means pg. 983
03/25/2021
Author added Greenman pg. 1366
04/09/2021
Author stricken Boe pg. 2068